Free Trial

OS Therapies (OSTX) Stock Chart & Stock Price History

OS Therapies logo
$2.95 -1.17 (-28.40%)
As of 01/17/2025 04:00 PM Eastern

OS Therapies Stock Price Performance

5 Day
Performance
-32.34%
1 Month
Performance
-25.69%
3 Month
Performance
-2.22%
Year-To-Date
Performance
-31.07%
Receive OSTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OS Therapies and its competitors with MarketBeat's FREE daily newsletter.

OSTX Stock Chart for Tuesday, January, 21, 2025

OS Therapies Stock Price History

DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
01/17/2025$4.12$2.95
-28.40%
$4.09$2.421.63 million shs$63.51 million
01/16/2025$4.36$4.12
-5.50%
$4.54$3.62579,063 shs$88.72 million
01/15/2025$4.16$4.36
+4.81%
$7.00$4.0719.03 million shs$93.88 million
01/14/2025$4.65$4.16
-10.54%
$4.70$4.0048,695 shs$89.58 million
01/13/2025$4.97$4.65
-6.44%
$5.39$4.6542,149 shs$100.13 million
01/10/2025$5.12$4.97
-2.93%
$5.36$4.7534,995 shs$105.55 million
01/09/2025$5.12$5.12$5.50$5.0047,086 shs$108.74 million
01/08/2025$4.90$5.12
+4.49%
$5.50$5.0047,086 shs$108.74 million
01/07/2025$4.76$4.90
+2.94%
$5.44$4.9051,110 shs$104.07 million
01/06/2025$4.26$4.76
+11.74%
$5.01$4.2567,437 shs$101.09 million
01/03/2025$4.18$4.26
+1.91%
$4.53$4.0754,341 shs$90.47 million
01/02/2025$4.28$4.18
-2.34%
$4.93$4.0164,763 shs$88.78 million
01/01/2025$4.28$4.28$4.96$3.9546,430 shs$90.90 million
12/31/2024$4.70$4.28
-8.94%
$4.96$3.9546,430 shs$90.90 million
12/30/2024$5.16$4.70
-8.91%
$5.93$4.3876,863 shs$99.82 million
12/27/2024$5.11$5.16
+0.98%
$5.59$4.4160,142 shs$109.59 million
12/26/2024$3.83$5.11
+33.42%
$5.55$3.73109,180 shs$108.53 million
12/25/2024$3.83$3.83$4.46$3.6393,044 shs$81.34 million
12/24/2024$3.78$3.83
+1.32%
$4.46$3.6393,044 shs$81.34 million
12/23/2024$3.97$3.78
-4.79%
$4.47$3.6565,553 shs$80.28 million
12/20/2024$3.91$3.97
+1.53%
$4.21$3.5361,426 shs$84.32 million
12/19/2024$4.09$3.91
-4.40%
$4.51$3.8027,642 shs$83.04 million


This page (NYSE:OSTX) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners